Patent details

Basic Information

Publication number:

EP2305256

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101837003

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers

French Title of Invention:

Composes de type uree aryle combines a d'autres agents cytostatiques ou cytotoxiques et servant a traiter des cancers humains

German Title of Invention:

Arylharnstoff-Verbindungen in Kombination mit anderen zytostatisch oder zytotoxisch wirksamen Stoffen zur Behandlung menschlicher Krebserkrankungen

SPC Number:

Dates

Filing date:

03/12/2002

Grant date:

24/10/2012

EP Publication Date:

24/10/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/04/2011

EP B1 Publication Date:

24/10/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/12/2012

Expiration date:

03/12/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/12/2002

 

 

Name:

Bayer HealthCare LLC

Address:

555 White Plains Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:

Hibner Barbara

Address:

United States (US)

2

Name:

Trail Pamela

Address:

United States (US)

3

Name:

Humphrey Rachel W.

Address:

United States (US)

4

Name:

Vincent Patrick

Address:

United States (US)

5

Name:

Carter Christopher A.

Address:

United States (US)

6

Name:

Zhai Yifan

Address:

United States (US)

7

Name:

Gibson Neil

Address:

United States (US)

Priority

Priority Number:

334609 P

Priority Date:

03/12/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/44;

Filing date	Document type	Number of pages